Shanghai ShenRay United Biomedical

ShenRay United (Shanghai) Biomedical Technology Co., Ltd. is a precision medicine company based in Shanghai, China, specializing in oncology diagnostics and personalized healthcare. Founded in 2014, the company utilizes advanced molecular biology techniques, including Next-Generation Sequencing (NGS), Circulating Tumor Cell (CTC) analysis, and liquid biopsy, to provide comprehensive genomic profiling for cancer patients. ShenRay United operates a state-of-the-art precision medicine center and has developed a robust oncology big data platform to support clinical decision-making. The company has received significant investment from prominent firms such as Sequoia China and Legend Capital. By collaborating with leading hospitals and research institutions, ShenRay United aims to bridge the gap between genomic research and clinical practice to improve cancer treatment outcomes.